Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
T1G
0.00%
0.0¢
Tiger Tasman Minerals Limited - TBA
Currently unlisted.
Proposed listing date: TBA
Add to my watchlist
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
T1G | IPO - Tiger Tasman Minerals Limited - 14 November 2022 12:00 PM AEDT ## | 10/02/24 | 4 | 3.7K | |||
|
|||||||
T1G | Listing soon | 14/09/23 | 38 | 20K | |||
|
|||||||
T1G Lithium | General Discussion | 13/05/23 | 4 | 2.9K | |||
|
See All Discussions